Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Discontinued OperationsCash from Discontinued OperationsCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Vycor Medical (VYCO) Change in Receivables (2016 - 2025)

Vycor Medical has reported Change in Receivables over the past 16 years, most recently at -$107161.0 for Q4 2025.

  • Quarterly Change in Receivables fell 1733.55% to -$107161.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$23678.0 through Dec 2025, down 170.88% year-over-year, with the annual reading at -$23678.0 for FY2025, 170.88% down from the prior year.
  • Change in Receivables was -$107161.0 for Q4 2025 at Vycor Medical, down from $126074.0 in the prior quarter.
  • Over five years, Change in Receivables peaked at $126074.0 in Q3 2025 and troughed at -$107161.0 in Q4 2025.
  • The 5-year median for Change in Receivables is -$15474.0 (2021), against an average of $3286.0.
  • The largest YoY upside for Change in Receivables was 909.93% in 2025 against a maximum downside of 1733.55% in 2025.
  • A 5-year view of Change in Receivables shows it stood at -$50788.0 in 2021, then skyrocketed by 52.05% to -$24354.0 in 2022, then tumbled by 64.39% to -$40035.0 in 2023, then skyrocketed by 116.39% to $6560.0 in 2024, then tumbled by 1733.55% to -$107161.0 in 2025.
  • Per Business Quant, the three most recent readings for VYCO's Change in Receivables are -$107161.0 (Q4 2025), $126074.0 (Q3 2025), and -$26745.0 (Q2 2025).